BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
302.49
-8.30 (-2.67%)
At close: Apr 6, 2026, 4:00 PM EDT
302.49
0.00 (0.00%)
Pre-market: Apr 7, 2026, 4:01 AM EDT
BeOne Medicines AG Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$374.75
Upside
+23.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $340 | Buy | Initiates | $340 | +12.40% | Mar 27, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $420 → $290 | Strong Buy → Hold | Downgrades | $420 → $290 | -4.13% | Mar 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $417 → $425 | Buy | Maintains | $417 → $425 | +40.50% | Feb 27, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $400 → $412 | Strong Buy | Maintains | $400 → $412 | +36.20% | Feb 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $400 → $410 | Strong Buy | Maintains | $400 → $410 | +35.54% | Feb 27, 2026 |
| Barclays | Barclays | Buy Maintains $394 → $405 | Buy | Maintains | $394 → $405 | +33.89% | Feb 27, 2026 |
| Barclays | Barclays | Buy Maintains $385 → $394 | Buy | Maintains | $385 → $394 | +30.25% | Feb 4, 2026 |
| Truist Securities | Truist Securities | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +32.24% | Nov 24, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $395 → $408 | Buy | Maintains | $395 → $408 | +34.88% | Nov 18, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $399 → $405 | Strong Buy | Maintains | $399 → $405 | +33.89% | Nov 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $374 → $395 | Buy | Maintains | $374 → $395 | +30.58% | Nov 7, 2025 |
| Citizens | Citizens | Buy Maintains $348 → $396 | Buy | Maintains | $348 → $396 | +30.91% | Nov 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $350 → $383 | Buy | Maintains | $350 → $383 | +26.62% | Oct 20, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $345 → $385 | Buy | Maintains | $345 → $385 | +27.28% | Oct 8, 2025 |
| Barclays | Barclays | Buy Initiates $385 | Buy | Initiates | $385 | +27.28% | Sep 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $349 → $364 | Buy | Maintains | $349 → $364 | +20.33% | Aug 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.